LEBVANAH

Serial Number 98565253
606

Registration Progress

Application Filed
May 23, 2024
Under Examination
Nov 19, 2024
Approved for Publication
Sep 24, 2024
Published for Opposition
Sep 24, 2024
Registered

Basic Information

Serial Number
98565253
Deadline
August 23, 2025
Description
Trademark Application Revival Due
Filing Date
May 23, 2024
Published for Opposition
September 24, 2024
Abandonment Date
June 23, 2025
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jun 23, 2025
Classes
005

Rights Holder

Eli Lilly and Company

03
Address
Lilly Corporate Center
Indianapolis, IN 46285

Ownership History

Eli Lilly and Company

Original Applicant
03
Indianapolis, IN

Eli Lilly and Company

Owner at Publication
03
Indianapolis, IN

Legal Representation

Attorney
Bruce W. Longbottom

USPTO Deadlines

All Deadlines Cleared

All 1 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

10 events
Date Code Type Description
Jun 23, 2025 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jun 23, 2025 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Nov 19, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 24, 2024 PUBO A PUBLISHED FOR OPPOSITION
Sep 24, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 4, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 18, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 15, 2024 DOCK D ASSIGNED TO EXAMINER
Aug 13, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 23, 2024 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases

Classification

International Classes
005